Literature DB >> 30521800

Does maternal age at retrieval influence the implantation potential of euploid blastocysts?

Mohamad Irani1, Nikica Zaninovic2, Zev Rosenwaks2, Kangpu Xu2.   

Abstract

BACKGROUND: Age-related decline in reproductive potential is mainly due to the increased incidence of aneuploidy. Furthermore, 2 recent studies have shown that euploid embryos of older women may have a lower implantation potential compared to those of younger women, suggesting that aging might compromise embryos beyond their ploidy status. However, the inherent limitations of these studies preclude solid conclusions.
OBJECTIVE: The aim of this study was to determine whether maternal age at retrieval affects the implantation potential of euploid blastocysts.
MATERIALS AND METHODS: This is a retrospective cohort study that was conducted at an academic medical center. Patients who underwent frozen-thawed euploid embryo transfers (FET) between 2013 and 2016 were included. Cycles were divided into the following 5 age groups: <35, 35-37, 38-40, 41-42, and >42 years of age. Blastocysts were assessed before biopsy and assigned the following morphological grades: excellent (3-6AA), good (3-6AB, 3-6BA), average (2-6BB), and poor (3-6BC, 3-6CB, 3-6CC). The main outcome measures were implantation (IR) and live birth (LBR) rates. Both χ2 and Fisher exact tests were used to compare categorical variables. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated and controlled for confounders.
RESULTS: A total of 785 FET cycles (870 blastocysts) were included. Excellent-quality blastocysts were associated with a significantly higher LBR compared with good-quality (78.8% vs 63.8%), average-quality (78.8% vs 54.2%), and poor-quality (78.8% vs 28.3%) counterparts. Poor-quality embryos yielded a higher spontaneous abortion (SAB) rate compared with average-, good-, and excellent-quality blastocysts (25.0%, 9.0%, 6.9%, and 2.4%, respectively). Embryos biopsied on day 5 had a significantly higher LBR compared with those biopsied on day 6 (60.0% vs 46.6%). The 5 age groups (<35, 35-37, 38-40, 41-42, and >42 years) had comparable IRs (56.5%, 52.9%, 55.4%, 59.1%, and 71.4%, respectively), LBRs (55.1%, 51.3%, 53.5%, 52.4%, and 61.9%, respectively), and SAB rates (8.8%, 7.9%, 8.3%, 14.3, and 13.3%, respectively). Older women had fewer euploid embryos, but they were of comparable morphology and developed at a similar rate to the blastocyst stage as compared to those of younger women.
CONCLUSION: Maternal age at retrieval influences the number of euploid embryos; however, contrary to previously published studies, it does not affect their implantation potential. The morphodynamic characteristics of embryos, as reflected by blastocyst morphology and speed of development, are critical for selecting among euploid embryos.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blastocyst morphological grading; day of trophectoderm biopsy; euploid embryo; maternal age; preimplantation genetic testing for aneuploidy (PGT-A)

Mesh:

Year:  2018        PMID: 30521800     DOI: 10.1016/j.ajog.2018.11.1103

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Lack of evidence to support the superiority of TLI over conventional morphology to select among euploid embryos determined by PGT-A.

Authors:  Yi Guo; Henan Zhang; Shuaishuai Guo
Journal:  J Assist Reprod Genet       Date:  2019-06-25       Impact factor: 3.412

2.  The impact of euploid blastocyst morphology and maternal age on pregnancy and neonatal outcomes in natural cycle frozen embryo transfers.

Authors:  Wendy Y Zhang; Jasmyn K Johal; Rebecca M Gardner; Brindha Bavan; Amin A Milki
Journal:  J Assist Reprod Genet       Date:  2022-02-05       Impact factor: 3.412

3.  The impact of age beyond ploidy: outcome data from 8175 euploid single embryo transfers.

Authors:  Andres Reig; Jason Franasiak; Richard T Scott; Emre Seli
Journal:  J Assist Reprod Genet       Date:  2020-03-16       Impact factor: 3.412

4.  Poor Embryo Quality Is Associated With A Higher Risk of Low Birthweight in Vitrified-Warmed Single Embryo Transfer Cycles.

Authors:  Jiaan Huang; Yu Tao; Jie Zhang; Xiaoyan Yang; Jiayi Wu; Yanping Kuang; Yun Wang
Journal:  Front Physiol       Date:  2020-05-15       Impact factor: 4.566

5.  Association between morphologic grading and implantation rate of Euploid blastocyst.

Authors:  Hua Lou; Na Li; Yichun Guan; Yuchao Zhang; Dayong Hao; Shihong Cui
Journal:  J Ovarian Res       Date:  2021-01-23       Impact factor: 4.234

6.  Comparing prediction of ongoing pregnancy and live birth outcomes in patients with advanced and younger maternal age patients using KIDScore™ day 5: a large-cohort retrospective study with single vitrified-warmed blastocyst transfer.

Authors:  Keiichi Kato; Satoshi Ueno; Jørgen Berntsen; Motoki Ito; Kiyoe Shimazaki; Kazuo Uchiyama; Tadashi Okimura
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

7.  Extended embryo culture is effective for patients of an advanced maternal age.

Authors:  R Sainte-Rose; C Petit; L Dijols; C Frapsauce; F Guerif
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 8.  Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements.

Authors:  Manuel Viotti
Journal:  Genes (Basel)       Date:  2020-05-29       Impact factor: 4.096

9.  Impact of Day 7 Blastocyst Transfer on Obstetric and Perinatal Outcome of Singletons Born After Vitrified-Warmed Embryo Transfer.

Authors:  Jiaan Huang; Xiaoyan Yang; Jiayi Wu; Yanping Kuang; Yun Wang
Journal:  Front Physiol       Date:  2020-02-12       Impact factor: 4.566

10.  The effects of aging on molecular modulators of human embryo implantation.

Authors:  Panagiotis Ntostis; Grace Swanson; Georgia Kokkali; David Iles; John Huntriss; Agni Pantou; Maria Tzetis; Konstantinos Pantos; Helen M Picton; Stephen A Krawetz; David Miller
Journal:  iScience       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.